Monopar TherapeuticsMNPR
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 43 institutions reported holding Monopar Therapeutics Inc. (MNPR) in their 13F filings, up 8 from Q1 2025. 19 opened new positions and 11 sold out. The largest holders were Janus Henderson Group PLC ($41.6M), Adage Capital Partners Gp, L.L.C. ($21.4M) and Ra Capital Management, L.P. ($18.3M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Monopar Therapeutics Inc.
- CUSIP
- 61023L207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 19 | $3.3M |
| Exits | 11 | $3.1M |
All 13F filers, Q1 2025 → Q2 2025: 487,118 shares bought and 196,652 shares sold, net +290,466 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| Janus Henderson Group PLC | 0.02% | Add +3.4% | 1,172,368 | $41.6M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | No change | 599,195 | $21.4M |
| Ra Capital Management, L.P. | 0.31% | No change | 511,207 | $18.3M |
| BlackRock, Inc. | 0.00% | Add +1318.5% | 205,169 | $7.3M |
| Point72 Asset Management | 0.01% | Reduce -38.1% | 104,019 | $3.7M |
| ADAR1 Capital Management, LLC | 0.59% | Add +0.2% | 100,974 | $3.6M |
| Geode Capital Management, LLC | 0.00% | Add +99.7% | 96,919 | $3.5M |
| Vanguard Group Inc. | 0.00% | Add +56.6% | 86,489 | $3.1M |
| Affinity Asset Advisors, LLC | 0.37% | Add +8.9% | 67,500 | $2.4M |
| State Street Corp. | 0.00% | Add +164.5% | 41,826 | $1.5M |
| Ally Bridge Group (NY) LLC | 1.03% | New | 34,537 | $1.2M |
| Northern Trust Corp. | 0.00% | Add +247.3% | 31,813 | $1.1M |
| UBS Group AG | 0.00% | Add +169.3% | 21,873 | $783K |
| Millennium Management | 0.00% | Reduce -75.5% | 14,789 | $529K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 13,249 | $474K |
| Bank of New York Mellon Corp | 0.00% | New | 8,948 | $320K |
| Susquehanna International Group, LLP | 0.00% | New | 8,356 | $299K |
| Morgan Stanley | 0.00% | Add +457.0% | 7,932 | $284K |
| Barclays PLC | 0.00% | Add +60608.3% | 7,285 | $261K |
| Citadel Advisors | 0.00% | New | 6,232 | $223K |
| Rhumbline Advisers | 0.00% | New | 5,850 | $209K |
| Gerber, LLC | 0.14% | No change | 5,601 | $200K |
| Deutsche Bank AG | 0.00% | New | 3,385 | $121K |
| New York State Common Retirement Fund | 0.00% | New | 2,900 | $104K |
| MetLife Investment Management, LLC | 0.00% | New | 2,538 | $91K |
| Wells Fargo & Company | 0.00% | Add +820.4% | 2,301 | $82K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 2,222 | $80K |
| Bank of America Corp. | 0.00% | Reduce -14.9% | 2,109 | $75K |
| JPMorgan Chase & Co. | 0.00% | Add +1821.0% | 1,921 | $69K |
| AlphaQuest LLC | 0.01% | Add +46.8% | 1,784 | $64K |
| Citigroup Inc. | 0.00% | Add +541.3% | 1,443 | $52K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | New | 964 | $34K |
| NewEdge Advisors, LLC | 0.00% | No change | 600 | $21K |
| Legal & General Group Plc | 0.00% | New | 453 | $16K |
| Raymond James Financial Inc. | 0.00% | New | 431 | $15K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 415 | $15K |
| BNP Paribas Financial Markets | 0.00% | New | 347 | $12K |
| California State Teachers Retirement System | 0.00% | New | 254 | $9K |
| Amalgamated Bank | 0.00% | New | 139 | $5K |
| Allworth Financial LP | 0.00% | No change | 100 | $4K |
| FMR LLC | 0.00% | New | 31 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -90.7% | 19 | $1K |
| Sterling Capital Management LLC | 0.00% | New | 10 | $358 |
"% of holder's portfolio" is MNPR's weight in each manager's 13F, not the share of Monopar Therapeutics Inc. the manager owns.